Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. - Wikidata - awgldk - TriplyDB

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.

http://www.wikidata.org/entity/Q43290056

about

The prediagnostic phase of Parkinson's disease Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease.Neuroimaging in Parkinson disease: from research setting to clinical practice.The role of biomarkers and imaging in Parkinson's disease.Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.Striatal and Hippocampal Atrophy in Idiopathic Parkinson's Disease Patients without Dementia: A Morphometric Analysis.Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.Subregional 6-[18F]fluoro-ʟ-m-tyrosine uptake in the striatum in Parkinson's disease.Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease Neuroimaging: current role in detecting pre-motor Parkinson's disease.Parkinson subtypes progress differently in clinical course and imaging pattern The influence of dopaminergic striatal innervation on upper limb locomotor synergies.A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease.Monoamine reuptake inhibitors in Parkinson's disease.Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.Imaging insights into basal ganglia function, Parkinson's disease, and dystonia Molecular imaging needles: dual-modality optical coherence tomography and fluorescence imaging of labeled antibodies deep in tissue.Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington's disease.Disease duration and the integrity of the nigrostriatal system in Parkinson's disease A review of disease progression models of Parkinson's disease and applications in clinical trials Dopamine overdose hypothesis: evidence and clinical implications.Disease progression in patients with single, large-scale mitochondrial DNA deletions.Development of Parkinson's disease biomarkers.Milestones in neuroimaging.Positron emission tomography imaging in neurological disorders.Biomarkers for trials of neuroprotection in Parkinson's disease.Functional neuroimaging in Parkinson's disease.Astrocytes in neurodegenerative disease.Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.Dopamine function and the efficiency of human movement.Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: a single photon emission computed tomography imaging study.Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease.

P2860

Q26768732-137C3940-9307-4351-BC3C-2259F5D7F5D2 Q30373366-EC9CE163-6BD1-43FA-9663-607800881B07 Q30491906-C0E98372-C55C-4856-9D9C-22C0493C5936 Q30868628-767DA8C0-7B57-4226-A38A-F961FCAC307F Q31041660-B47E8B90-85E7-4805-82A1-09A0D34E14C1 Q31158920-A494519C-07C4-41AC-8026-AA5533507F8E Q33559200-981BE51B-9B5B-45DC-BE7F-C2694CB81072 Q33602588-8CDE5F77-DB73-4FCE-BD21-29E4F8CCF29A Q33853332-1D506C4A-1EBB-4ACA-A9EF-51D470D02CD1 Q34185526-8286ED0E-EEE7-4661-BBD2-8328EBFA07FD Q34234625-668060E6-B72E-448A-99DE-391C825D64D5 Q34442161-91AEA891-A1D2-4E67-8E2B-3677ECB6C941 Q34511022-FEACCC43-4B19-4655-B179-C8F358BD95A1 Q34616968-8508CDD0-3325-45AB-8347-DEA91E82C86C Q34999207-463EE736-2706-4FB9-8F84-231B4D656AEA Q35034718-92143FAB-C085-42E6-B9F4-0A0378418035 Q35072636-E01EAA6F-70FB-4DC9-ABBC-DB63457EB196 Q35165280-7E9A29B9-8465-44FB-AF50-8040F206DBA2 Q35183919-3FF8900E-1B3B-4873-9A65-AF7C5BA4A699 Q35193033-D3C68F68-5C98-43C0-BBAB-60AAB87D6194 Q35681540-3536071C-ADAF-4A72-B5F5-2E24385971D0 Q35792439-F9C3AB50-615F-4C5D-80E3-2B713D34A575 Q35980553-E4F82AED-2136-4948-BE8F-CE4568831223 Q36309073-5B854635-2A30-4390-A775-E2F1C02F6F89 Q37043102-DEE2ED6E-BCDA-427B-8B53-351A6991EEBF Q37062838-E641CEDB-8995-4EFB-9076-EB0A582F723D Q37384960-52CE4FC3-FFE0-4DF3-B044-210AD696ED7F Q37557004-16E7FC89-2887-484A-882D-E7C1AE0E69AC Q37810992-F29C7B8D-26F6-4B4D-ABB0-A2490CD77766 Q37882576-EF803177-40D1-4588-B8E1-5254EE8A6E79 Q37980609-46D7F943-01E4-43F8-8488-7E4C067BD972 Q38038544-D3A3CDFF-52A5-4753-B9CA-6E180B3BEF70 Q38088371-FEEB625A-B7EA-4194-9120-36D4887B8E98 Q38422519-BF7C453D-C627-4611-9870-9FF33B7D56AC Q38881337-A07D74AD-6119-4CC1-B720-BBF288F6F6BC Q38951947-16C08AC7-5169-4D79-ACA0-42F1B0FFF8EA Q38994712-8C33AC22-3F6E-4A5C-80B1-E60ACE1486F0 Q39420262-FFD67F47-D3F8-429C-A510-B585A30D09C9 Q39828634-5E63F060-DF55-4680-A292-27D02CB08008 Q40090298-534E3140-5893-4FC6-BBA8-FAFA80DE368D

P2860

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.

http://www.wikidata.org/entity/Q43290056

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Longitudinal progression of sp ...... ron emission tomography study.

@en

Longitudinal progression of sp ...... ron emission tomography study.

@nl

type

label

Longitudinal progression of sp ...... ron emission tomography study.

@en

Longitudinal progression of sp ...... ron emission tomography study.

@nl

prefLabel

Longitudinal progression of sp ...... ron emission tomography study.

@en

Longitudinal progression of sp ...... ron emission tomography study.

@nl

P1433

Q43290056-A427D365-FB0A-48B5-B660-15B4F2969147

P1476

Q43290056-FDB247C0-5EB5-4CF5-A6AD-A058BD3E6061

P2093

Q43290056-0EC8F939-1160-43EB-BA9C-E3A895E595DF

Q43290056-126C1C09-760C-45A1-90DC-D82D8E877537

Q43290056-23298EF9-3AFD-4D71-B4C9-005E4A7CE798

Q43290056-2FD5E8A5-977F-4FDA-802C-76EF4C3808B9

Q43290056-409382CE-0035-487A-8255-FB4918B61F31

Q43290056-43FFD6A1-945F-4E87-8DE5-AE144D9840E6

Q43290056-58EF1A92-335A-4A1A-BB4E-2BA9C9F8A35D

Q43290056-5C141D86-AE49-4545-9726-F1EC47DC7CBA

Q43290056-6578F3C0-2BF7-4F5D-B883-071EB394E4AE

Q43290056-6E6CB84B-FF40-4ACC-ACD3-EAF04D91B733

P2860

Q43290056-02B9F8EB-5371-4742-8A33-99A4F6EF8AB5

Q43290056-10C04A3F-B175-4E87-BC0A-9CCE195791D1

Q43290056-1EE17B35-C58D-4BA0-9BC6-726E49EC69E3

Q43290056-25829C02-F1B9-4756-ADF9-95E88F9BDD3C

Q43290056-2A769530-5F39-4EF9-81D1-A492EFC4AE46

Q43290056-3B313349-C64A-437C-90B5-B15296249FF9

Q43290056-462E054C-CC7D-4147-97A7-8697B14CCD8B

Q43290056-48F19029-FF01-4FD4-B12C-3C9A8966A64D

Q43290056-4DADCA6E-851F-433C-A38F-5C8A022E8237

Q43290056-56F927FC-E229-441F-BC2F-CA64468B0BBF

P304

Q43290056-5853A8DE-23A7-424B-8C86-E9C897A7AC50

P31

Q43290056-A3503940-9A00-4EFD-AC5A-A7BF67D3A1AD

P356

Q43290056-86F70E68-60EF-4967-92BD-FC2021BF3F3D

P407

Q43290056-D8D5821C-DD73-4210-B0C5-5728A1F47A74

P433

Q43290056-6BC6978E-DADB-4F76-ABB8-283CCAF05B32

P478

Q43290056-0E27CBA1-F32A-45B7-81E9-F89A4DD2526A

P50

Q43290056-62E966E7-E138-4684-A459-33CC4B7D01B0

P577

Q43290056-7BEB79BA-8BF8-4EF4-B704-387D8AB1E70C

P5875

Q43290056-BB3E3988-F286-4D55-86AB-CFE32CF2D4BD

P698

Q43290056-CAED223E-91E8-4C36-96A1-83F34C48042B

P921

Q43290056-A5BC75D6-C2FA-4BDF-99BB-A22194DBB4F5

P356

P1433

P1476

Longitudinal progression of sp ...... ron emission tomography study.

@en

P2093

A J Stoessl

http://www.w3.org/2001/XMLSchema#string

A Samii

http://www.w3.org/2001/XMLSchema#string

A Troiano

http://www.w3.org/2001/XMLSchema#string

Chong S Lee

http://www.w3.org/2001/XMLSchema#string

E Mak

http://www.w3.org/2001/XMLSchema#string

J Cragg

http://www.w3.org/2001/XMLSchema#string

J McKenzie

http://www.w3.org/2001/XMLSchema#string

L Kuramoto

http://www.w3.org/2001/XMLSchema#string

M Schulzer

http://www.w3.org/2001/XMLSchema#string

R Nandhagopal

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Ageing and Parkinson's disease: substantia nigra regional selectivity

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Molecular pathways of neurodegeneration in Parkinson's disease

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

Non-linear random effects model for multivariate responses with missing data.

Relationship of striatal dopamine synthesis capacity to age and cognition.

P304

2970-2979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWP209

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 11

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Donald Brian Calne

P577

2009-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26750878

http://www.w3.org/2001/XMLSchema#string

P698

19690093

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease